These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30879473)

  • 1. Rewriting the (tran)script: Application to spinal muscular atrophy.
    Ratni H; Mueller L; Ebeling M
    Prog Med Chem; 2019; 58():119-156. PubMed ID: 30879473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).
    Ratni H; Ebeling M; Baird J; Bendels S; Bylund J; Chen KS; Denk N; Feng Z; Green L; Guerard M; Jablonski P; Jacobsen B; Khwaja O; Kletzl H; Ko CP; Kustermann S; Marquet A; Metzger F; Mueller B; Naryshkin NA; Paushkin SV; Pinard E; Poirier A; Reutlinger M; Weetall M; Zeller A; Zhao X; Mueller L
    J Med Chem; 2018 Aug; 61(15):6501-6517. PubMed ID: 30044619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing therapeutics in SMN2 and APOB.
    Khoo B; Krainer AR
    Curr Opin Mol Ther; 2009 Apr; 11(2):108-15. PubMed ID: 19330716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts.
    Farrelly-Rosch A; Lau CL; Patil N; Turner BJ; Shabanpoor F
    Neurochem Int; 2017 Sep; 108():213-221. PubMed ID: 28389270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy.
    Zhao X; Feng Z; Ling KK; Mollin A; Sheedy J; Yeh S; Petruska J; Narasimhan J; Dakka A; Welch EM; Karp G; Chen KS; Metzger F; Ratni H; Lotti F; Tisdale S; Naryshkin NA; Pellizzoni L; Paushkin S; Ko CP; Weetall M
    Hum Mol Genet; 2016 May; 25(10):1885-1899. PubMed ID: 26931466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1687():143-155. PubMed ID: 29067661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy.
    Vitte J; Attali R; Warwar N; Gurt I; Melki J
    Adv Exp Med Biol; 2009; 652():237-46. PubMed ID: 20225030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of single-stranded nucleic acids by small-molecule splicing modulators.
    Tang Z; Akhter S; Ramprasad A; Wang X; Reibarkh M; Wang J; Aryal S; Thota SS; Zhao J; Douglas JT; Gao P; Holmstrom ED; Miao Y; Wang J
    Nucleic Acids Res; 2021 Aug; 49(14):7870-7883. PubMed ID: 34283224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic Acid-Targeted Small Molecules have Therapeutic Potential in the Treatment of Spinal Muscular Atrophy: Small-molecule drugs that can selectively bind RNA and modulate pre-mRNA splicing have potential as a treatment strategy for human disease, including spinal muscular atrophy.
    Am J Med Genet A; 2018 Aug; 176(8):1698-1699. PubMed ID: 30136439
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence.
    Marquis J; Meyer K; Angehrn L; Kämpfer SS; Rothen-Rutishauser B; Schümperli D
    Mol Ther; 2007 Aug; 15(8):1479-86. PubMed ID: 17505471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental regulation of SMN expression: pathophysiological implications and perspectives for therapy development in spinal muscular atrophy.
    Jablonka S; Sendtner M
    Gene Ther; 2017 Sep; 24(9):506-513. PubMed ID: 28556834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risdiplam: First Approval.
    Dhillon S
    Drugs; 2020 Nov; 80(17):1853-1858. PubMed ID: 33044711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational development of splice-modifying antisense oligomers.
    Fletcher S; Bellgard MI; Price L; Akkari AP; Wilton SD
    Expert Opin Biol Ther; 2017 Jan; 17(1):15-30. PubMed ID: 27805416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large animal model of spinal muscular atrophy and correction of phenotype.
    Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
    Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of RNA splicing in the pathogenesis of spinal muscular atrophy and development of its therapeutics].
    Sahashi K; Sobue G
    Brain Nerve; 2014 Dec; 66(12):1471-80. PubMed ID: 25475034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity, synergy, and mechanisms of splice-modifying drugs.
    Ishigami Y; Wong MS; Martí-Gómez C; Ayaz A; Kooshkbaghi M; Hanson SM; McCandlish DM; Krainer AR; Kinney JB
    Nat Commun; 2024 Feb; 15(1):1880. PubMed ID: 38424098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
    Coady TH; Shababi M; Tullis GE; Lorson CL
    Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
    Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
    Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.